HomeCompareRCDTF vs QYLD

RCDTF vs QYLD: Dividend Comparison 2026

RCDTF yields 2.77% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RCDTF wins by $27.2K in total portfolio value
10 years
RCDTF
RCDTF
● Live price
2.77%
Share price
$56.95
Annual div
$1.58
5Y div CAGR
32%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52.6K
Annual income
$9,708.55
Full RCDTF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — RCDTF vs QYLD

📍 RCDTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCDTFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCDTF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCDTF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCDTF
Annual income on $10K today (after 15% tax)
$235.82/yr
After 10yr DRIP, annual income (after tax)
$8,252.27/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, RCDTF beats the other by $3,441.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCDTF + QYLD for your $10,000?

RCDTF: 50%QYLD: 50%
100% QYLD50/50100% RCDTF
Portfolio after 10yr
$39.0K
Annual income
$7,683.94/yr
Blended yield
19.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QYLD right now

RCDTF
Analyst Ratings
2
Hold
1
Sell
Consensus: Hold
Altman Z
3.4
Piotroski
5/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCDTF buys
0
QYLD buys
0
No recent congressional trades found for RCDTF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCDTFQYLD
Forward yield2.77%11.92%
Annual dividend / share$1.58$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32%0%
Portfolio after 10y$52.6K$25.4K
Annual income after 10y$9,708.55$5,659.31
Total dividends collected$28.6K$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RCDTF vs QYLD ($10,000, DRIP)

YearRCDTF PortfolioRCDTF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$11,066$366.22$10,352$1,192.36+$714.00RCDTF
2$12,341$499.95$10,830$1,347.57+$1.5KRCDTF
3$13,892$687.80$11,460$1,539.07+$2.4KRCDTF
4$15,820$955.18$12,275$1,777.84+$3.5KRCDTF
5$18,269$1,341.86$13,323$2,078.95+$4.9KRCDTF
6$21,460$1,911.67$14,667$2,463.34+$6.8KRCDTF
7$25,732$2,770.17$16,396$2,960.57+$9.3KRCDTF
8$31,631$4,097.76$18,631$3,612.97+$13.0KRCDTF
9$40,060$6,214.06$21,548$4,482.15+$18.5KRCDTF
10$52,572$9,708.55$25,398$5,659.31+$27.2KRCDTF

RCDTF vs QYLD: Complete Analysis 2026

RCDTFStock

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Full RCDTF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this RCDTF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCDTF vs SCHDRCDTF vs JEPIRCDTF vs ORCDTF vs KORCDTF vs MAINRCDTF vs XYLDRCDTF vs JEPQRCDTF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.